Iovance Biotherapeutics Inc Corporate Call Transcript
Good day, and thank you for standing by. Welcome to the Iovance corporate update call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Sara Pellegrino, Senior Vice President, Investor Relations and Corporate Communications. Please go ahead.
Thank you, operator. Good morning, and thank you for joining our conference call to discuss the ongoing Biologics License Application, or BLA submission, for lifileucel, our new TIL therapy for patients with advanced melanoma. Earlier this morning, we issued a press release about the BLA submission that can also be found on our corporate website at iovance.com.
On today's call, Dr. Fred Vogt, our Interim President and Chief Executive Officer, will provide a brief introduction and summary. Then we will hold a question-and-answer session where several members of our executive leadership team are available to participate. Dr.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |